info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Primary Biliary Cholangitis (PBC) Market By Drug Type (Ursodeoxycholic Acid, Obeticholic Acid, and Other Drugs); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Biliary Cholangitis (PBC) Market will witness a robust CAGR of 8.01 % , valued... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Alpha Glucosidase Inhibitors Market By Drug Type (Acarbose, Miglitol, Voglibose, Others); By Indication (Type 2 Diabetes Mellitus, Prediabetes, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Glucosidase Inhibitors Market will witness a robust CAGR of 8.1% , valued at $1.32 billion in 2024 , expected to appreciate and reach $2.11 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Nicotine Replacement Therapy Market By Product Type (Gum, Patch, Inhaler, Nasal Spray, Lozenges); By Route of Administration (Oral, Nasal, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nicotine Replacement Therapy (NRT) Market will witness a robust CAGR of 6.7%, valued at $3.86 billion in 2024 , expected to appreciate an... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Predictive Genetic Testing and Consumer Genomics Market By Product Type (Predictive Testing Kits, Consumer Genomic Services, Carrier and Pharmacogenomics Kits); By Application (Disease Risk Assessment, Ancestry & Traits, Pharmacogenetics, Reproductive Planning); By End User (Direct Consumers, Hospitals & Clinical Labs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Predictive Genetic Testing And Consumer Genomics Market will witness a robust CAGR of 11.8%, valued at $9.4 billion in 2024 , and is proj... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Bronchodilators Market By Drug Class (Beta-2 Adrenergic Agonists, Anticholinergics, Theophylline, Combination Therapies); By Route of Administration (Inhalation, Oral, Injectable); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Others); By End User (Hospitals, Retail Pharmacies, Homecare Settings, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bronchodilators Market will witness a robust CAGR of 6.7 % , valued at $17.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Sustained Release Excipients Market By Product Type (Polymers [Natural, Synthetic], Coatings [Functional, Osmotic], Minerals, Gums & Lipids); By Formulation Type (Oral Tablets, Capsules, Injectables, Implants); By Route of Administration (Oral, Parenteral, Transdermal, Others); By End User (Pharmaceutical Companies, CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sustained Release Excipients Market will witness a robust CAGR of 7.1% , valued at $2.97 billion in 2024 , and is expected to appreciate and reach $4.79 billion by... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Relapsed and Refractory Multiple Myeloma Treatment Market Relapsed and Refractory Multiple Myeloma (RRMM) Treatment Market By Treatment Modality (Immunomodulatory Drugs, Proteasome Inhibitors, Monoclonal Antibodies, CAR-T Cell Therapy, Bispecific Antibodies); By Line of Therapy (Second-Line Therapy, Third-Line and Beyond); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Relapsed And Refractory Multiple Myeloma Treatment Market will witness a robust CAGR of 7.4% , valued at $16.8 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Ovarian Cancer Drugs Market By Drug Type (Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Drugs); By Treatment Approach (First-Line Treatment, Second-Line Treatment, Adjuvant Therapy); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ovarian Cancer Drugs Market will witness a robust CAGR of 7.6% , valued at $5.3 billion in 2024 , and is projected to reach $9.2 ... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Predictive Biomarkers Market By Biomarker Type (Genomic, Proteomic, Metabolomic, Epigenetic, Cell-Based); By Application (Oncology, Autoimmune, Cardiovascular, Neurology, Infectious Diseases); By End User (Pharma & Biotech, Hospitals, Diagnostic Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Predictive Biomarkers Market will witness a robust CAGR of 14.8% , valued at USD 9.8 billion in 2024 , and is expected to appreciate and reach USD 22.6 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

OTC Dry Eye Drops Market By Product Type (Artificial Tears, Lubricant Eye Drops, Gel Drops, Specialty Formulations); By Formulation (Preservative-Free, With Preservatives); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies & E-commerce, Supermarkets/Hypermarkets); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global OTC Dry Eye Drops Market will witness a robust CAGR of 6.8% , valued at USD 3.42 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Muscle Relaxant Drugs Market By Drug Class (Centrally Acting Skeletal Muscle Relaxants, Direct-Acting Muscle Relaxants); By Route of Administration (Oral, Injectable); By Application (Musculoskeletal Conditions, Neurological Disorders, Perioperative and ICU Care); By End User (Hospitals, Outpatient Clinics, Rehabilitation Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Muscle Relaxant Drugs Market will witness a robust CAGR of 5.8% , valued at $2.34 billion in 2024, expected to appreciate and reach $3.29 billion by 2030,... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Blood Screening Market By Technology (Nucleic Acid Testing, Immunoassay); By Product & Service (Reagents & Kits, Instruments, Software & Services); By End User (Blood Banks, Hospitals & Clinics, Plasma Fractionation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blood Screening Market will witness a steady CAGR of 9.2 % , valued at approximately $ 5.3 billion in 2024 , and is proj... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Tuberculosis Therapeutics Market By Drug Class (First-Line Therapy, Second-Line Therapy); By Disease Type (Active TB, Latent TB); By Route of Administration (Oral, Injectable); By Distribution Channel (Public Programs, Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tuberculosis Therapeutics Market will witness a steady CAGR of 6.1% , valued at $1.34 billion in 2024 , and is expected to reach $1.91 billion by 2030 , c... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Alpha Emitter Market By Isotope Type (Actinium-225, Radium-223, Astatine-211, Lead-212, Others); By Application (Prostate Cancer, Bone Metastases, Leukemia & Lymphoma, Neuroendocrine Tumors, Others); By End User (Hospitals & Oncology Clinics, Radiopharmacies, Academic Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Emitter Market will witness a strong CAGR of 13.7% , valued at $990 million in 2024 , and is projected to grow significantly to reach around $2.15 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Iron Deficiency Anemia Therapy Market By Therapy Type (Oral Iron Supplements, Intravenous Iron Therapy, Erythropoiesis-Stimulating Agents); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Clinics, Homecare, Specialty Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Iron Deficiency Anemia Therapy Market will witness a robust CAGR of 8.1% , valued at USD 3.9 billion in 2024 , expected to appreciate and reach US... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Animal Model Market By Animal Type (Mice, Rats, Pigs, Non-Human Primates, Others); By Application (Toxicology Testing, Disease Research, Drug Discovery, Others); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic and Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Animal Model Market is set to experience steady growth from USD 2.5 billion in 2024 , with a projected market size of USD 4.5 billion by 2030 , reflecting... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Herpes Simplex Virus Treatment Market by Treatment Type (Antiviral Drugs, Vaccines); By Type of Infection (HSV-1, HSV-2); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Herpes Simplex Virus ( HSV ) Treatment Market is poised for significant growth, expected to grow at a CAGR of 5.7% valued at USD 9.8 billionRead More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

High Performance Liquid Chromatography Market By Product Type (Instruments, Consumables, Accessories); By Application (Pharmaceutical and Biotech Drug Development, Clinical Diagnostics, Food & Beverage Testing, Environmental Analysis, Forensic Science); By End User (Pharma Companies, CROs, Academic Institutes, Testing Labs, Government Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global High Performance Liquid Chromatography ( HPLC ) Market will witness a steady CAGR of 6.4%, valued at approximately $6.2 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Cell Penetrating Peptide Market By Product Type (Short Peptides, Long Peptides, Hybrid Peptides); By Application (Drug Delivery, Gene Therapy, Cancer Therapy, Regenerative Medicine); By End-User (Pharmaceutical & Biotech Companies, Research Institutions, Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Cell Penetrating Peptide (CPP) Market will experience substantial growth from USD 2.7 billion in 2024 to an estimated USD 10.24 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Traumatic Brain Injury Biomarkers Market By Biomarker Type (Protein, Metabolomic, Genomic, MicroRNA, Others); By Application (Diagnostic, Prognostic, Drug Discovery & Clinical Trials, Monitoring & Therapeutics); By Sample Type (Blood, CSF, Saliva, Urine); By End User (Hospitals, Military, Research Institutes, Sports Organizations, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Traumatic Brain Injury ( TBI ) Biomarkers Market will witness a robust CAGR of 9.4% , valued at USD 2.17 billion in 2024 , and is expecte... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Antimicrobial Resistance (AMR) Testing Market Antimicrobial Resistance Testing Market By Technology (Culture-based, Molecular, Whole Genome Sequencing, Automated Systems); By Pathogen Type (Gram-negative, Gram-positive, Mycobacterium, Fungi, Viruses); By End User (Hospitals, Public Health, Research, Independent Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimicrobial Resistance ( AMR ) Testing Market will witness a steady CAGR of 5.3 % , valued at USD 6.5... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Roadside Drug Testing Devices Market By Product Type (Handheld Testing Devices, Bench-top Analyzers); By Drug Type Detected (Cannabis, Cocaine, Opioids, Amphetamines, Others); By End User (Law Enforcement Agencies, Highway Patrol Agencies, Forensic Laboratories, Workplace Testing Organizations); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Roadside Drug Testing Devices Market will witness a robust CAGR of 8.1% , valued at USD 1.05 billion in 2024 , expected to appreciate and reach US... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Saliva Collection and Diagnostics Market By Product Type (Saliva Collection Devices, Saliva Diagnostic Kits & Assays); By Application (Infectious Disease Detection, Genetic and Genomic Testing, Cancer Biomarker Detection, Drug Abuse and Toxicology Testing, Hormone and Metabolic Testing); By End User (Diagnostic Laboratories, Hospitals and Clinics, Research Institutes and Academic Centers, Home Care and Direct-to-Consumer Testing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Saliva Collection And Diagnostics Market will witness a robust CAGR of 9.2% , valued at approximately $ 4.1 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Substance Abuse Treatment Market By Treatment Type (Medication-Assisted Treatment, Behavioral Therapies & Counseling, Residential/Inpatient Treatment, Outpatient Treatment Programs); By Substance Type (Alcohol Dependence, Opioid Dependence, Cannabis Use Disorder, Cocaine and Stimulant Addiction, Prescription Drug Abuse, Others); By End User (Hospitals, Specialty Rehabilitation Centers, Private Clinics and Individual Practitioners, Government & Community Organizations, Telehealth and Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Substance Abuse Treatment Market will witness a robust CAGR of 6.8% , valued at $21.3 billion in 2024 , expected to appreciate and reach $31.7 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Erythropoietin Drugs Market By Drug Class (Epoetin Alfa, Darbepoetin Alfa, Epoetin Beta, Others); By Application (Chronic Kidney Disease, Cancer, HIV, Surgical Procedures, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erythropoietin Drugs Market will witness a robust CAGR of 8.2% , valued at $ 11.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation); By Indication (B-cell NHL, T-cell NHL); By End-User (Hospitals, Oncology Clinics, Research Centers, Outpatient Treatment Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The global Non-Hodgkin Lymphoma (NHL) Therapeutics Market is expected to experience robust growth, reaching a market value of $15.2 billion in 2024 and growing to $32.5 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Precision Diagnostics Market By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, Digital PCR & Emerging Techniques); By Application (Oncology, Infectious Diseases, Reproductive Health, Rare Diseases, Neurology, Cardiology, Others); By End User (Hospitals & Clinical Laboratories, Reference Laboratories, Academic & Research Institutions, Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Precision Diagnostics Market will witness a robust CAGR of 10.4%, valued at $98.6 billion in 2024, expected to appreciate and reach $177.4 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Oncolytic Virus Immunotherapy Market By Type of Oncolytic Virus (Genetically Modified Viruses, Wild-Type Viruses); By Application (Cancer Treatment, Combination Therapies); By End-User (Hospitals & Clinics, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oncolytic Virus Immunotherapy Market will witness a significant CAGR of 7.65 % , valued at $ 5.64 billion in 2024 , and is projected to g... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

At-Home Testing Kits Market By Test Type (Infectious Disease Testing Kits, Chronic Disease Monitoring Kits, Fertility and Pregnancy Testing Kits, Genetic and DNA Testing Kits, Substance Abuse and Drug Testing Kits, Wellness and Lifestyle Testing Kits); By Sample Type (Blood-Based, Saliva-Based, Urine-Based, Others); By Distribution Channel (Retail Pharmacies, Online Platforms/E-commerce, Supermarkets/Hypermarkets, Direct-to-Consumer Company Websites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global At-Home Testing Kits Market will witness a robust CAGR of 7.8% , valued at USD 11.7 billion in 2024, expected to appreci... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Cancer Biomarkers Market By Biomarker Type (Genetic, Protein, Epigenetic, Cell-based, Metabolic); By Cancer Type (Breast, Lung, Colorectal, Prostate, Melanoma, Others); By Application (Diagnosis, Prognostics, Therapeutic Monitoring, Drug Discovery, Screening); By Technology (NGS, PCR, IHC, Mass Spectrometry, Others); By End User (Hospitals, Reference Labs, Biopharma, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Biomarkers Market will witness a robust CAGR of 13.6% , valued at $ 26.8 billion in 2024 , and is expected to appreciate and reach... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Inhalable Drugs Market by Product Type (MDIs, DPIs, Nebulizers); By Application (Asthma, COPD, Other Respiratory Disorders); By End-User (Hospitals, Clinics, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inhalable Drugs Market will witness a robust CAGR of 6.3% , valued at $20.5 billion in 2024 , expected to appreciate and reach $3... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

HBA1c Testing Devices Market By Product Type (Laboratory-Based Analyzers, Point-of-Care Devices); By Technology (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Others); By End User (Hospitals and Clinics, Diagnostic Laboratories, Homecare and Retail Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global HBA1c Testing Devices Market will witness a robust CAGR of 9.2% , valued at $1.95 billion in 2024 , expected to apprecia... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Hereditary Cancer Testing Market By Product Type (Next-Generation Sequencing, PCR, Microarrays, Others); By Application (Breast Cancer, Ovarian Cancer, Colorectal Cancer, Others); By End-User (Hospitals & Clinics, Research Centers, Direct-to-Consumer Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hereditary Cancer Testing Market will witness a robust CAGR of 10.6% , valued at $6.5 billion in 2024 , expected to appreciate and reach $Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Blood Collection Devices Market By Product Type (Blood Collection Needles & Syringes, Blood Collection Tubes, Lancets, Blood Bags, Vacuum Blood Collection Systems, Others); By Method (Manual Blood Collection, Automated Blood Collection); By Application (Diagnostics, Therapeutics, Research and Biobanking); By End User (Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, Home Healthcare & Point-of-Care Testing, Research Institutes & Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blood Collection Devices Market will witness a robust CAGR of 6.8% , valued at approximately $10.2 billion in 2024 , expected to appreciate and reach arou... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Optical Emission Spectroscopy Market By Product Type (Arc/Spark OES Systems, Inductively Coupled Plasma OES Systems); By Application (Metallurgy & Foundries, Environmental Analysis, Petrochemicals & Energy, Semiconductors & Electronics, Others); By End User (Industrial Manufacturing, Independent Analytical Laboratories, Research Institutes & Universities, Government & Regulatory Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Optical Emission Spectroscopy ( OES ) Market will witness a robust CAGR of 6.9% , valued at USD 862.4 million in Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Tourette Syndrome Treatment Market By Treatment Type (Pharmacological Treatments, Behavioral Therapy, Surgical Interventions); By Drug Class (Antipsychotic Drugs, Alpha-2 Adrenergic Agonists, Anticonvulsants, Others); By End User (Hospitals & Clinics, Specialty Care Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tourette Syndrome Treatment Market is expected to witness a robust compound annual growth rate (CAGR) of 6.5% , with a market value of USD 1.2 bil... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Latent Tuberculosis Infection Detection Market By Test Type (Tuberculin Skin Test, Interferon-Gamma Release Assays, Molecular Diagnostic Tests); By End User (Hospitals and Clinics, Diagnostic Laboratories, Occupational Health Screening Centers, Public Health Programs and NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Latent Tuberculosis Infection Detection Market is projected to witness a robust CAGR of 8.2% , valued at approximately USD 1.1 billion in 2024, and expect... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Cellular Immunotherapy Market By Therapy Type (CAR-T, TCR, NK Cell, Dendritic Cell, TIL); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Diseases, Infectious Diseases); By Source (Autologous, Allogeneic); By End User (Hospitals, Academic Institutes, Cell Therapy Centers, Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cellular Immunotherapy Market will witness a robust CAGR of 21.6% , valued at $7.8 billion in 2024 , and is expected to appreciate and reach $25.4 billion by 2030<... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

In-vitro Colorectal Cancer Screening Tests Market By Test Type (FIT, FOBT, Stool DNA, Blood-Based Biomarkers, Others); By Biomarker (DNA Markers, RNA Markers, Protein Markers, Hemoglobin, Microbiome Markers); By End User (Hospitals, Diagnostic Laboratories, Academic & Research Institutions, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global In-Vitro Colorectal Cancer ( CRC ) Screening Tests Market will witness a robust CAGR of 8.9% , valued at $3.1 billion in 2024 , and is ex... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Retinoblastoma Treatment Market By Treatment Type (Chemotherapy, Radiation Therapy, Surgery, Targeted Therapy, Gene Therapy); By Disease Stage (Localized, Metastatic); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Retinoblastoma Treatment Market is projected to experience significant growth, driven by ongoing advancements in medical technology, early diagnosis, and increasing awareness of the condition. Retinoblastoma, a r... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

CRISPR-based Diagnostics Market By Product Type (Diagnostic Kits, Instruments); By Application (Infectious Diseases, Cancer Diagnostics, Genetic Disorders); By End User (Hospitals & Clinics, Research Institutions, Public Health Agencies); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The CRISPR -Based Diagnostics Market is expected to experience substantial growth, driven by continuous advancements in genetic engineering technologies. Valued at $1.5 billion in 20... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Pseudomonas Aeruginosa Infection Treatment Market By Drug Class (Beta-lactam Antibiotics, Aminoglycosides, Fluoroquinolones, Biologics, Phage Therapy, Combination Therapies); By Route of Administration (Injectable, Oral, Inhaled, Topical); By Indication Type (HAP & VAP, UTIs, BSIs, Cystic Fibrosis, Surgical Site Infections); By End User (Hospitals, Clinics, Outpatient, Military Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pseudomonas Aeruginosa Infection Treatment Market will witness a promising CAGR of 7.2% , valued at USD 5.8 billion in 2024 , and is expected to reach around USD 9... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Corticosteroids Market By Product Type (Systemic Corticosteroids, Topical Corticosteroids, Inhaled Corticosteroids, Ophthalmic Corticosteroids, Intranasal Corticosteroids); By Route of Administration (Oral, Parenteral, Topical, Inhaled, Ophthalmic, Intranasal); By Application (Respiratory Diseases, Dermatological Disorders, Autoimmune & Inflammatory Disorders, Ophthalmic Conditions, Endocrine Disorders, Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Corticosteroids Market will witness a robust CAGR of 6.74 % , valued at $16.2 billion in 2024, expected to appreciate and reach $21.4 billionRead More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Lung Cancer Diagnostics Market By Type of Test (Imaging Tests, Biopsy and Histopathology, Molecular and Biomarker Testing, Liquid Biopsy); By Technology (Immunohistochemistry, Polymerase Chain Reaction, Next-Generation Sequencing, Fluorescence In Situ Hybridization, Imaging Technologies); By End User (Hospitals, Cancer Diagnostic Centers, Reference Laboratories, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lung Cancer Diagnostics Market will witness a robust CAGR of 9.3% , valued at $3.8 billion in 2024 , expected to appreciate and reach $6.5 billion... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Sarcoma Drugs Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy); By Therapeutic Approach (Adjuvant, Neoadjuvant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sarcoma Drugs Market is projected to witness a steady growth rate, with an anticipated CAGR of 7.3% from 2024 to 2030. Valued at $2.5 billion in 2024, it ... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Neurological Biomarkers Market By Biomarker Type (Genomic, Proteomic, Metabolomic, Imaging, Electrophysiological); By Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Traumatic Brain Injury, Autism Spectrum Disorders, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Biopharma, CROs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neurological Biomarkers Market will witness a robust CAGR of 14.7 %, valued at $ 8.7 billion in Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Malignant Glioma Therapeutics Market By Therapeutic Type (Chemotherapy, Immunotherapy, Targeted Therapy); By Drug Class (Chemotherapeutic Agents, Monoclonal Antibodies, Immunomodulatory Agents); By End User (Hospitals, Specialized Oncology Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Malignant Glioma Therapeutics Market will witness a robust growth trajectory, with a projected compound annual growth rate ( CAGR ) of 8.5% . Valued at Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

PARP Inhibitor Market By Drug Type (Olaparib, Niraparib, Rucaparib, Talazoparib, Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PARP Inhibitor Market will witness a sustained CAGR of 12.6% , valued at $5.1 billion in 2024 , and is expected to appreciate and reach <... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Pediatric Cardiac Tumor Diagnostics Market By Diagnostic Modality (Echocardiography, MRI, CT, Molecular Testing); By Tumor Type (Benign, Malignant); By End User (Pediatric Hospitals, Diagnostic Imaging Centers, Research Institutes); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Cardiac Tumor Diagnostics Market will witness a robust CAGR of 6.9% , valued at approximately USD 426.7 million in 2024 , expec... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market By Biomarker Type (Liver Enzyme Markers, Genetic Markers, Proteomic Markers); By Diagnostic Method (Blood-Based Tests, Imaging Techniques, Genetic Testing); By Application (Diagnosis, Disease Progression Monitoring); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non - Alcoholic Steatohepatitis ( NASH ) Biomarkers Market will witness significant growth in the comin... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Rare Disease Genetic Testing Market By Test Type (NGS, WES, WGS, Targeted Panels, CMA, Sanger Sequencing); By Sample Type (Blood, Saliva, Buccal Swab, Amniotic Fluid, Biopsy); By Application (Prenatal Screening, Carrier Testing, Diagnostic, Predictive, Pharmacogenomics); By End User (Hospitals, Specialty Labs, Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rare Disease Genetic Testing Market will witness a robust CAGR of 15.4 % , valued at $3.92 billion in 2024 , expected to appreciate ... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Antihypertensive Drugs Market By Product Type (ACE Inhibitors, Calcium Channel Blockers, Diuretics, Beta-blockers, ARBs); By Therapeutic Class (Monotherapy, Combination Therapy); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Antihypertensive Drugs Market will experience a steady growth trajectory from 2024 to 2030, driven by the increasing prevalence of hypertension globally, especially among aging populations. The global market for ... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Glioblastoma Multiforme Treatment Market By Treatment Type (Surgical Procedures, Chemotherapy, Radiation Therapy, Targeted Therapies, Immunotherapies); By End-User (Hospitals, Clinics, Research Centers, Oncology Centers); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Glioblastoma Multiforme ( GBM ) Treatment Market is anticipated to exhibit robust growth over the forecast period from 2024 to 2030. Glioblastom... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Microneedle Flu Vaccine Market By Product Type (Solid, Dissolving, Coated, Hollow); By Route of Administration (Transdermal, Intradermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Vaccination Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microneedle Flu Vaccine Market will witness a robust CAGR of 18.4% , valued at $516 million in 2024 , expected to appreciate and reach $1.43 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Skin Testing Equipment Market By Product Type (Skin Prick Test Devices, Intradermal Test Devices, Patch Test Kits, Automated Testing Systems); By Application (Food Allergies, Drug Allergies, Environmental Allergies, Contact Dermatitis); By End User (Hospitals and Specialty Clinics, Diagnostic Centers, Pharmacies and Wellness Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Testing Equipment Market is poised to witness a robust CAGR Of 6.5% , valued at USD 1.8 Billion In 2024 , and is projected to reach ... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Isolator Box Glove Market By Material Type (Nitrile, Butyl Rubber, Neoprene, Hypalon, Natural Rubber, Polyurethane); By Configuration (Ported Glove, Sleeve-Glove Systems, Single-Use Disposable Gloves, Multi-Use / Reusable Gloves); By End Use (Pharmaceutical and Biotech Manufacturing, Nuclear Industry, Semiconductor and Microelectronics, Research Laboratories, Medical Device Assembly, Chemical and Petrochemical Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Isolator Box Glove Market is projected to reach USD 1.12 Billion By 2030 , up from USD 730 Million In 2024 , expanding at a CAGR<... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Spiral CT Scan Machine Market By Product Type (Single-Slice Spiral CT, Multi-Slice Spiral CT, High-Slice & Dual-Source Spiral CT); By Application (Cardiology, Oncology, Neurology, Orthopedics & Musculoskeletal); By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Mobile & Military Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spiral CT Scan Machine Market is projected to witness steady growth, expanding from an estimated value of USD 4.3 Billion In 2024 to USD 6.9 Billion By 2030 , growing at a... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Diphenhydramine Market By Product Type (Branded, Generic); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diphenhydramine Market is projected to expand steadily between 2024 and 2030, growing at a Cagr Of 5.8% . Valued at around USD 350 Million In 2024... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Salt Therapy Market By Product Type (Halotherapy Rooms, Salt Inhalers, Salt Lamps, Salt-Based Skincare Products); By Application (Respiratory Health, Dermatology, Wellness & Relaxation); By End User (Hospitals & Clinics, Wellness Centers & Spas, Home Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Salt Therapy Market will witness a robust CAGR Of 6.5 % , valued at $2.3 Billion In 2024 , expected to appreciate and reach $3.3 ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Smart Microbial Detecting Equipment Market By Product Type (Biosensors, Lab-on-Chip Systems, Automated Culture-Based Systems, Portable Microbial Detectors); By Application (Healthcare and Clinical Diagnostics, Food and Beverage Safety, Pharmaceutical and Biotech, Environmental Monitoring); By End User (Hospitals and Diagnostic Labs, Pharmaceutical Manufacturers, Food Processing Plants, Research and Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Smart Microbial Detecting Equipment Market will witness a robust CAGR Of 11.5%, valued at $3.2 Billion In 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Thromboelastography Machine Market By Product Type (Standalone Systems, Portable/POC Devices, Consumables & Accessories); By Application (Cardiovascular Surgery, Trauma & Emergency Care, Transplant Surgery, Obstetrics, Liver & Hematologic Disorders); By End User (Hospitals & Surgical Centers, Diagnostic Labs, Ambulatory Surgical Centers, Military & Field Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thromboelastography Machine Market is poised for accelerated growth between 2024 and 2030 , expanding at a projected CAGRRead More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Biomedical Tester Market By Product Type (Electrical Safety Analyzers, Defibrillator Analyzers, Patient Simulator Testers, Infusion Pump Analyzers, Ventilator and Gas Flow Analyzers); By Application (Critical Care Equipment Testing, Surgical and OR Equipment, Diagnostic Imaging Systems, Home Healthcare Devices); By End User (Hospitals and Clinics, OEMs and Device Manufacturers, Third-Party Service Providers, Regulatory and Compliance Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biomedical Tester Market is projected to expand steadily from a base value of USD 1.2 Billion In 2024 , growing at a CAGRRead More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Hemoperfusion Cartridge Market By Product Type (Charcoal-Based, Resin-Based, Others); By Application (Renal Disorders, Sepsis, Drug Overdose, Others); By End User (Hospitals, Dialysis Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemoperfusion Cartridge Market will witness a robust CAGR Of 10.4% , valued at USD 1.12 Billion In 2024 , and is projected to reach around USD 2.0... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Sleep Aid Devices Market By Product Type (Wearable Devices, Non-Wearable Devices, Smart Digital Solutions); By Application (Insomnia Management, Sleep Apnea & Respiratory Support, Stress-Related Sleep Aids, General Wellness & Sleep Optimization); By End User (Individual Consumers, Clinics & Hospitals, Corporate Wellness Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sleep Aid Devices Market will witness a robust CAGR Of 7 .8% , valued at $6.2 Billion In 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Peripheral T-cell Lymphoma (PTCL) Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Disease Subtype (PTCL-NOS, AITL, ALCL, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Cancer Specialty Clinics, Academic & Research Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral T -Cell Lymphoma (PTCL) Treatment Market will witness a robust CAGR of 7.4%, valued at $1.61 billion ... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Graft Versus Host Disease (GVHD) Treatment Market By Treatment Type (Corticosteroids, Monoclonal Antibodies, JAK Inhibitors, Calcineurin Inhibitors, Extracorporeal Photopheresis, Others); By Disease Type (Acute GVHD, Chronic GVHD); By Route of Administration (Oral, Intravenous, Topical); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Graft Versus Host Disease (GVHD) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.2 billion in 2024 , and is expected t... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Angina Pectoris Drugs Market By Drug Class (Nitrates, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, Ranolazine and Novel Anti-Anginals); By Route of Administration (Oral, Intravenous, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Angina Pectoris Drugs Market will witness a robust CAGR of 5.7% , valued at $9.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Scleroderma Therapeutics Market By Drug Class (Immunosuppressants, Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Others); By Route of Administration (Oral, Parenteral, Topical); By Disease Type (Localized Scleroderma, Systemic Scleroderma, SSc-PAH, Renal Involvement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Scleroderma Therapeutics Market will witness a robust CAGR of 6.6% , valued at $3.42 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Neglected Tropical Disease (NTD) Treatment Market Neglected Tropical Disease Treatment Market By Drug Type (Antiparasitic, Antibacterial, Antiviral, Supportive Therapies, Vaccines); By Disease Type (Leishmaniasis, Chagas Disease, Lymphatic Filariasis, Schistosomiasis, Onchocerciasis, Others); By Route of Administration (Oral, Parenteral, Topical, Inhalational); By Distribution Channel (Government Programs, Hospitals, Pharmacies, NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neglected Tropical Disease Treatment Market will witness a robust CAGR of 8.9% , valued at $2.78 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Hairy Cell Leukemia Market By Treatment Modality (Purine Analogs, BRAF Inhibitors, Monoclonal Antibodies, Other Combination Therapies); By Diagnostic Technology (Flow Cytometry, Molecular Testing, Immunohistochemistry); By End User (Specialty Oncology Centers, Academic & Research Hospitals, Community Hematology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hairy Cell Leukemia Market will witness a robust CAGR of 7.23 % , valued at $0.78 billion in 2024 , exp... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

NUT Midline Carcinoma Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Route of Administration (Oral, Intravenous, Others); By Diagnostic Method (IHC, FISH, NGS, PCR); By End User (Hospitals & Academic Medical Centers, Specialty Cancer Clinics, Diagnostic Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global NUT Midline Carcinoma Treatment Market will witness a robust CAGR of 16.3%, valued at around $48.2 million in 2024,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Skeletal Dysplasia Market By Type of Disorder (Achondroplasia, Hypophosphatasia, Osteogenesis Imperfecta, Thanatophoric Dysplasia, Others); By Treatment Modality (Pharmacological Therapy, Surgical Intervention, Gene Therapy, Assistive Devices); By Diagnostic Technique (Radiographic Imaging, Genetic Testing, Prenatal Diagnosis); By End User (Hospitals, Specialized Clinics, Diagnostic Labs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Skeletal Dysplasia Market will witness a robust CAGR of 7.8% , valued at $2.14 billion in 2024 , and is expected to appreciate and reach $3.37 bil... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Antisense and RNAi Therapeutics Market By Therapeutic Type (Antisense Oligonucleotides, RNA Interference); By Application (Genetic Disorders, Oncology, Neurodegenerative Diseases, Ophthalmology, Infectious Diseases); By Route of Administration (Intravenous, Subcutaneous, Intrathecal, Others); By End User (Biopharmaceutical Companies, Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antisense And RNAi Therapeutics Market will witness a robust CAGR of 17.4% , valued at $5.8 billion in 2024 , expected t... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Acute Lymphocytic Lymphoblastic Leukemia Therapeutics Market Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Oncology Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market will witness a robust CAGR of 8.7% , valued at $3.5 Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Estrogen Receptor Positive (ER+) Breast Cancer Treatment Market By Drug Class (SERMs, Aromatase Inhibitors, SERDs, CDK4/6 Inhibitors, PI3K/AKT/mTOR Inhibitors, Others); By Line of Therapy (Adjuvant, Neoadjuvant, Metastatic/Advanced); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Estrogen Receptor Positive (ER +) Breast Cancer Treatment Market will witness a robust CAGR of 6.5 % , ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Artemisinin Combination Therapy Market By Drug Combination Type (Artemether-Lumefantrine, Artesunate-Amodiaquine, DHA-Piperaquine, Artesunate-Mefloquine, Others); By Route of Administration (Oral, Parenteral, Rectal Suppositories); By End User (Public Health Systems, Private Hospitals, NGOs, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artemisinin Combination Therapy Market will witness a robust CAGR of 6.8% , valued at $2.42 billion in 2024 , and is expected to appreciate and reach $3.6 billion ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Periodontal Therapeutics Market By Product Type (Systemic Antibiotics, Local Antibiotic Delivery Agents, Anti-inflammatory Agents, Regenerative Therapeutics, Host Modulation Agents, Others); By Mode of Administration (Oral, Injectable, Topical); By End User (Dental Clinics, Hospitals, Academic & Research Institutions, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Periodontal Therapeutics Market will witness a robust CAGR of 6.5% , valued at $8.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Fabry Disease Treatment Market By Treatment Type (Enzyme Replacement Therapy, Pharmacological Chaperones, Gene Therapy, Substrate Reduction Therapy); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Infusion Centers, Specialty Clinics & Genetic Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Fabry Disease Treatment Market will witness a robust CAGR of 11.4% , valued at $2.15 billion in 2024, expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Myelodysplastic Syndrome Drugs Market By Drug Class (Hypomethylating Agents, Immunomodulatory Drugs, Targeted Therapies, Supportive Care Drugs); By Route of Administration (Oral, Injectable); By End User (Hospitals, Oncology Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myelodysplastic Syndrome (MDS) Drugs Market will witness a robust CAGR of 10.1% , valued at USD 2.1 billion in 2... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Particle Therapy Market By Therapy Type (Proton Therapy, Heavy Ion Therapy); By Cancer Type (Pediatric Cancer, Head and Neck Cancer, Prostate Cancer, Lung Cancer, Ocular Tumors, Others); By End User (Hospitals, Specialized Cancer Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Particle Therapy Market will witness a robust CAGR of 10.7% , valued at approximately $4.32 billion in 2024 , and is projected to reach <... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Cystic Fibrosis Therapeutics Market By Drug Type (CFTR Modulators, Antibiotics, Mucolytics, Others); By Route of Administration (Oral, Inhalation, Injectables); By End User (Hospitals, Pharmacies, Home Care, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cystic Fibrosis Therapeutics Market is positioned to grow at a robust CAGR of 8.5% , valued at $5.4 billion in 2024 , and is expected to ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Methicillin-Resistant Staphylococcus Aureus Drugs Market By Drug Class (Glycopeptides, Oxazolidinones, Lipopeptides, Cephalosporins, Tetracyclines, Others); By Route of Administration (Oral, Parenteral, Topical); By Indication (Skin and Soft Tissue Infections, Bloodstream Infections, Pneumonia, Bone and Joint Infections, Others); By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutions, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market will witness a promising CAGR of 6.4 % ... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Irritable Bowel Syndrome Treatment Market By Product Type (Prescription Drugs, Over-the-Counter Drugs, Probiotics, Digital Therapeutics); By IBS Subtype (IBS-C, IBS-D, IBS-M, IBS-U); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Telehealth Platforms); By End User (Hospitals, Gastroenterology Clinics, ASCs, Self-care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Irritable Bowel Syndrome (IBS) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.84 billion in 2024 , expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Immune Checkpoint Inhibitors Market By Drug Type (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Others); By Cancer Type (Lung, Melanoma, Bladder, Breast, Liver, Others); By End User (Hospitals & Cancer Centers, Academic Institutes, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Checkpoint Inhibitors Market will witness a robust CAGR of 13.8% , valued at $42.3 billion in 2024 , and is expected to appreciate and reach $102.1 billion ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Attention Deficit Hyperactivity Disorder (ADHD) Market By Drug Type (Stimulants, Non-Stimulants); By Demographic Group (Children and Adolescents, Adults); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Attention Deficit Hyperactivity Disorder (ADHD) Market will witness a robust CAGR of 7.5 %, valued at $19.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Primary Immunodeficiency Market By Disease Type (Antibody Deficiencies, Combined Immunodeficiencies, Phagocytic Cell Disorders, Complement Deficiencies, Others); By Treatment Type (Immunoglobulin Replacement Therapy, Targeted Biologics, Hematopoietic Stem Cell Transplantation, Gene Therapy, Supportive Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals & Specialty Clinics, Homecare Settings, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Immunodeficiency Market is projected to witness a robust CAGR of 7.8% , valued at USD 8.9 billion in 2024, and expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Thalassemia Market By Type (Alpha Thalassemia, Beta Thalassemia); By Treatment (Blood Transfusion, Iron Chelation Therapy, Gene Therapy, Bone Marrow/Stem Cell Transplantation, Others); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thalassemia Market will witness a steady CAGR of 8.5%, valued at $1.89 billion in 2024 , and is expected to expand and reach $Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Empty Capsules Market By Capsule Type (Gelatin, Vegetarian, Others); By End-User Application (Pharmaceutical, Nutraceutical, Cosmetic); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Empty Capsules Market will witness a robust CAGR of 5.6% , valued at USD 5.6 billion in 2024 , expected to appreciate and reach U... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Plasma Protease C1-Inhibitor Market By Product Type (Plasma-Derived C1-Inhibitor, Recombinant C1-Inhibitor); By Route of Administration (Intravenous, Subcutaneous); By Indication (Hereditary Angioedema, Acquired Angioedema, Other Complement Disorders); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Plasma Protease C1 -Inhibitor Market will witness a robust CAGR of 7.4% , valued at USD 1.14 billion in 2024 , and is expected to appreci... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Pediatric Diabetes Therapeutics Market By Type (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus); By Therapeutic Modality (Insulin Therapy, Oral Hypoglycemics, Adjunctive Therapies, CGM Systems, Insulin Delivery Devices); By Route of Administration (Injectable, Oral, Transdermal); By End User (Hospitals, Pediatric Specialty Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Diabetes Therapeutics Market will witness a robust CAGR of 8.5 % , valued at $12.6 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

HPV Associated Disorders Market By Product Type (Prophylactic Vaccines, Therapeutic Vaccines, Diagnostic Assays, Topical and Systemic Treatments); By Indication (Cervical Cancer, Genital Warts, Oropharyngeal Cancers, Recurrent Respiratory Papillomatosis); By End User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Public Health Agencies & NGOs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global HPV Associated Disorders Market will witness a robust CAGR of 7.2% , valued at USD 4.8 billion in 2024 , expected to appreciate and reach USD 7.8 ... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Postpartum Depression Drugs Market By Drug Class (Selective Serotonin Reuptake Inhibitors, Neuroactive Steroids, Tricyclic Antidepressants, Atypical Antidepressants, Others); By Route of Administration (Oral, Intravenous, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postpartum Depression (PPD) Drugs Market will witness a robust CAGR of 28.6% , valued at $1.72 billion in 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Enzyme Replacement Therapy Market By Product Type (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa, Alglucosidase Alfa, Idursulfase, Others); By Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enzyme Replacement Therapy (ERT) Market will witness a strong CAGR of 7.3%, valued at approximately $11.8 billion in 2024 , and is p... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Anticoagulant Reversal Drugs Market By Drug Type (Vitamin K Antagonist Reversal Agents, Heparin and LMWH Reversal Agents, Direct Oral Anticoagulant Reversal Agents); By Route of Administration (Intravenous, Oral); By End User (Hospitals and Trauma Centers, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The global anticoagulant reversal drugs market will witness a robust CAGR of 9.2% , valued at $1.24 billion in 2024 , expected to appreciate and reach $2.32 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Fungal Keratitis Treatment Market By Treatment Type (Topical Antifungal Therapy, Systemic Antifungal Therapy, Surgical Interventions, Adjunct Therapies); By Route of Administration (Topical, Oral, Intravenous, Ocular Injections); By End User (Hospitals, Specialty Eye Clinics, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fungal Keratitis Treatment Market will witness a robust CAGR of 6.3 % , valued at USD 1.14 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Central Nervous System (CNS) Therapeutics Market By Drug Class (Small Molecule Drugs, Biologics and Advanced Therapies); By Indication (Neurodegenerative Diseases, Psychiatric Disorders, Epilepsy and Seizure Disorders, Multiple Sclerosis, Pain Management and Neuropathic Pain); By Route of Administration (Oral, Injectable, Transdermal/Others); By End User (Hospitals & Specialty Clinics, Retail & Online Pharmacies, Research & Academic Institutes, Mental Health Centers, Military & Veteran Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Central Nervous System (CNS) Therapeutics Market will witness a robust CAGR of 8.6 % , valued at USD 138.2 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Hyperlipidemia Drugs Market By Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibrates, Niacin, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hyperlipidemia Drugs Market will witness a robust CAGR of 6.5% , valued at USD 16.8 billion in 2024, and is expected to appreciate and re... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Idiopathic Pulmonary Fibrosis Treatment Market By Drug Type (Antifibrotic Agents, Corticosteroids, Immunosuppressants, Others); By Mechanism of Action (TGF-β Inhibition, Tyrosine Kinase Inhibition, Anti-inflammatory Modulation, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Idiopathic Pulmonary Fibrosis Treatment Market will witness a robust CAGR of 7.8% , valued at $3.1 billion in 2024 , expected to appreciate and reach $5.2 billion ... Read More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Superdisintegrants Market By Product Type (Synthetic, Natural, Co-Processed); By Formulation Type (Tablets, Capsules, Orodispersible Tablets, Others); By Therapeutic Area (Cardiovascular, Neurological, Gastrointestinal, Infectious Diseases, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Superdisintegrants Market will witness a robust CAGR of 6.94 % , valued at approximately USD 460 million in 2024 , and i... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Conjugate Vaccine Market By Type (Monovalent, Multivalent); By Disease Indication (Pneumococcal, Meningococcal, Hib, Typhoid, Others); By Age Group (Pediatrics, Adults, Geriatrics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Conjugate Vaccine Market will witness a robust CAGR of 8.3 % , valued at $14.1 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485